<DOC>
	<DOC>NCT01206348</DOC>
	<brief_summary>To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne</brief_summary>
	<brief_title>Combination Treatment for Moderate to Severe Acne</brief_title>
	<detailed_description>A Phase IV, Open-Label Study Evaluating the treatment for Combination Acne Therapy.</detailed_description>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment) pregnancy and allergies</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Acne</keyword>
</DOC>